A Message from the ESMO President By Ogkologos - March 17, 2020 660 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR ASCO20 Virtual Research Round Up Podcast: Head and Neck Cancer and... August 13, 2020 Most Tattoo Artists Want to Show Off Their Work. These Nipple... August 2, 2019 ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ March 8, 2019 EMA Recommends Granting a Marketing Authorisation for Relacorilant October 2, 2026 Load more HOT NEWS Combination of Temozolomide and Capecitabine Associated with Improved PFS Compared to... Inpatient Mammography May Help Solve Issue of Low Screening Rates, Especially... EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate CCDI Activities Enhance NCI’s Childhood and AYA Cancer Research
